Majdoleen Alalawneh

5PUBLICATIONS
12CO-AUTHORS
PharmacogenomicsRespiratory diseasesTraditional Chinese medicine and treatmentsHaematological tumoursPacific Peoples medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 07, 2024
Pharmacokinetics of single-dose rivaroxaban under fed state in obese vs. non-obese subjects: An open-label controlled clinical trial (RIVOBESE-PK).

Majdoleen Alalawneh, Ahmed Awaisu, Ibtihal Abdallah

|Oct 10, 2023
Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data.

Majdoleen Alalawneh, Ousama Rachid, Ibtihal Abdallah

|Oct 14, 2022
Improving Syrian refugees' knowledge of medications and adherence following a randomized control trial assessing the effect of a medication management review service.

Majdoleen Alalawneh, Alberto Berardi, Nabeel Nuaimi

|Oct 06, 2022
Rivaroxaban Pharmacokinetics in Obese Subjects: A Systematic Review.

Majdoleen Alalawneh, Ahmed Awaisu, Ousama Rachid

|Apr 08, 2020
A randomized control trial assessing the effect of a pharmaceutical care service on Syrian refugees' quality of life and anxiety.

Majdoleen Al Alawneh, Nabeel Nuaimi, Eman Abu-Gharbieh

Pageof 1

Frequent Collaborators

3 joint publications

Ahmed Awaisu

3 joint publications

Ousama Rachid

2 joint publications

Iman A Basheti

2 joint publications

Ibtihal Abdallah